Zaid Talal graduated with a Bachelor of Science in Medical Laboratory Technology in 2018 and obtained his MPhil in Medical Biotechnology and Microbiology from the University of Peshawar, Pakistan, in 2024 with distinction. In 2025, he joined the TJ-lab as a doctoral student. His research interests focus on tumor immunology, extracellular vesicles, developing therapeutic antibodies, and exploring innovative cancer treatment strategies.

Representative Papers:

Al-Qadhi, Z. T. A., Babaresh, W. M. A., Rehman, I. U., Abdo Hassen, R. S., Allah, A., Ali, S. A., Al-Mansoub, H., Al-Samai, F., & Retas, Y. N. (2025). Genotype and Association of the XRCC1 Gene With Liver Disease in Chronic HCV Patients. Asian Pacific journal of cancer prevention: APJCP, 26(4), 1385–1391.

Yin L, Zhou S, Zhang H, Yao C, Al-Qadhi, Z. T. A, Shang Y, Wu S, Jin T. (2025). Reprogramming the tumor microenvironment: synergistic mechanisms of antibody-drug conjugates and immune checkpoint inhibitors. Antib Ther. 8(3):262-274. doi: 10.1093/abt/tbaf017. PMID: 40989107; PMCID: PMC12451267.

Al-Qadhi, Z. T. A., Babaresh, W. M., Rehman, I. U., Hassen, R. S. A., Nayyar, M., Rettas, Y., Shakeel, S. J., Huriya, S., Begum, A., & Khan, O. (2025). Association of XRCC1 Gene Polymorphism with an Increased Risk of Hepatocellular Carcinoma in the Peshawar Population. Asian Pacific Journal of Cancer Prevention: APJCP, 26(6), 2109–2115.